Synaptic abnormalities are a cardinal feature of Alzheimer's disease (AD) that are known to
arise as the disease progresses. A growing body of evidence suggests that pathological …

Significance: Alzheimer's disease (AD) is the most common cause of dementia in the elderly.
AD is currently ranked as the sixth leading cause of death, but some sources put it as third …

BackgroundExperimental studies indicate that lithium may facilitate neurotrophic/protective
responses in the brain. Epidemiological and imaging studies in bipolar disorder, in addition …

Alzheimer's disease (AD) is the most common form of dementia characterized by presence
of extracellular amyloid plaques and intracellular neurofibrillary tangles composed of tau …

Lithium remains the drug of first choice for prophylactic treatment of bipolar disorder,
preventing the recurrences of manic and depressive episodes. The longitudinal experiences …

The prevalence of Alzheimer's disease (AD), a progressive neurodegenerative disorder, is
expected to more than double by 2050. Studies on the pathophysiology of AD have been …

The ApoE4 allele is the most well-studied genetic risk factor for Alzheimer's disease, a
condition that is increasing in prevalence and remains without a cure. Precision nutrition …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
cognitive decline and memory loss. Despite advances in understanding the …

Importance Lithium is a naturally occurring and trace element that has mood-stabilizing
effects. Maternal therapeutic use of lithium has been associated with adverse birth …

Currently, in psychiatry, lithium is a drug of choice as a mood stabilizer in the maintenance
treatment of bipolar disorder for the prevention of manic and depressive recurrences. The …